Related Experiment Video
Updated: Nov 16, 2025

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
A polydopamine-coated LAPONITE®-stabilized iron oxide nanoplatform for targeted multimodal imaging-guided
Mengxue Liu1, Jiulong Zhang2, Xin Li1
1State Key Laboratory of Modification of Chemical Fibers and Polymer Materials, College of Chemistry, Chemical Engineering and Biotechnology, Donghua University, Shanghai 201620, People's Republic of China. xshi@dhu.edu.cn ruiguo@dhu.edu.cn.
Abstract:
The development of theranostic nanoplatforms with accurate diagnosis and effective therapy performance is crucial for precision medicine applications. Herein, we developed a novel targeted theranostic nanoplatform for magnetic resonance (MR) and photoacoustic (PA) imaging-guided photothermal therapy of cancer cells overexpressing sialic acid (SA). Firstly, LAPONITE® (LAP)-stabilized Fe3O4 nanoparticles (NPs) with a high r2 relaxivity were synthesized by a coprecipitation method, and then polydopamine (PDA) was coated to improve the photothermal effect and PA contrast effect, followed by the modification of PEGylated phenylboronic acid (PEG-PBA) to introduce tumor-targeting specificity into SA-overexpressed cancer cells. The formed LAP-Fe3O4@PDA-PEG-PBA NPs show excellent biocompatibility and photothermal conversion efficiency under near-infrared laser irradiation and are able to be used for dual modal MR/PA imaging of a xenografted tumor model and induce complete eradication of tumors after NIR laser treatment. In summary, LAP-Fe3O4@PDA-PEG-PBA NPs could be theranostic nanoplatforms for sensitive MR/PA imaging and effective photothermal therapy of SA-overexpressed tumors.
More Related Videos
06:42Plasmonic Photothermal Cancer Therapy: Nanoparticle-embedded Tumor-tissue-mimicking Phantoms for Visualizing Photothermal Temperature Distribution
Published on: May 9, 2025
08:03Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016